Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526994 · ClinicalTrials.gov registry record · Phase 2
Randomized Controlled Trial of Routine Screening for IPV
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 2,700
- Enrollment target
NCT00526994 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 2,700 participants.
The verdict
NCT00526994, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2,700 participants
- Enrollment target
Study Summary
This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.
Interventions
- OTHER screened
- BEHAVIORAL universal education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00526994
The ClinicalTrials.gov registry entry for NCT00526994 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 2,700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which screened is the first listed.
NCT00526994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00526994 about?
NCT00526994 is a clinical study titled "Randomized Controlled Trial of Routine Screening for IPV". This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.
What is the current status of trial NCT00526994?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,700 participants. The study started on 2008-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00526994?
The interventions under investigation include: screened (OTHER), universal education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00526994?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.